Cerebral Palsy Research Program Authorization Act of 2025
Cerebral Palsy Research Program Authorization Act of 2025 (HR 2178) SummaryThe Cerebral Palsy Research Program Authorization Act of 2025 (HR 2178) is a bill introduced in the U.S.
Cerebral Palsy Research Program Authorization Act of 2025 (HR 2178) SummaryThe Cerebral Palsy Research Program Authorization Act of 2025 (HR 2178) is a bill introduced in the U.S.
The Cerebral Palsy Research Program Authorization Act of 2025 (HR 2178) is a bill introduced in the U.S. House of Representatives that aims to establish and authorize funding for a new federal research program focused on cerebral palsy.
The main provisions of the bill include:
Establishing the Cerebral Palsy Research Program: The bill would direct the Secretary of Health and Human Services to establish a Cerebral Palsy Research Program within the National Institutes of Health (NIH).
Authorizing Funding: The bill would authorize $50 million in annual appropriations for the Cerebral Palsy Research Program from fiscal year 2026 through fiscal year 2030.
Research Priorities: The program would be required to focus research efforts on improving understanding of the causes of cerebral palsy, developing new treatments and therapies, and enhancing the quality of life for individuals living with cerebral palsy.
Stakeholder Engagement: The program would be required to regularly consult with key stakeholders, including medical experts, cerebral palsy advocacy organizations, and individuals with cerebral palsy and their families.
If enacted, the Cerebral Palsy Research Program Authorization Act of 2025 could have several significant impacts:
Increased Funding for Cerebral Palsy Research: The $50 million in annual funding could substantially boost research efforts and lead to new discoveries and advancements in understanding and treating cerebral palsy.
Improved Quality of Life: By prioritizing research to enhance the quality of life for individuals with cerebral palsy, the program could lead to the development of new assistive technologies, therapeutic interventions, and other supports.
Stronger Stakeholder Engagement: The requirement to regularly consult with key stakeholders could help ensure that the research program is responsive to the needs and perspectives of the cerebral palsy community.
Overall, the Cerebral Palsy Research Program Authorization Act of 2025 represents a significant federal investment in addressing a complex and often overlooked neurological condition that affects individuals throughout their lifetimes.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.